🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks to all who stopped by my poster today - feeling very inspired at my first in person AACR! #AACR2023

Pivotal research by Memorial Sloan Kettering Cancer Center's Sarat Chandarlapaty, MD, PhD, contributed to the recent approval of Elacestrant for people w/ advanced or metastatic ESR1-mutant #breastcancer. Congrats to all who made this incredible advance possible! #bcsm mskcc.org/news/msk-disco…

Deeply appreciative of everyone who helped develop #MSKimpact, #MSKaccess, #MPath, OncoKB™, cBioPortal, and of the physicians, scientists, nurses, administrators, clinic staff, couriers & accessioners who deliver precision diagnostics day after day. MSK Department of Pathology & Laboratory Medicine MSKCC Center for Molecular Oncology (CMO)

Hard to believe it has been 25 yrs Memorial Sloan Kettering Cancer Center. Thanks to my mentors, colleagues, mentees, patients and family who have taught and supported me along the way. Seems like a good time to look back at progress made in cancer research and treatment and hopes for the future. 1/x

Super work by superstar Tri-I CBM PhD student Madison Darmofal 👇 #MSKimpact

Yesterday, President Biden announced my appointment as a White House Fellow whitehouse.gov/briefing-room/… As the first oncologist ever selected, I'm excited to lead, serve, and innovate for our patients in this new role with the Cancer Moonshot and Health Outcomes teams White House Office of Science & Technology Policy

As promised here's a quick tweetorial for our Cancer Discovery article: Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer bit.ly/46X72vj 👇👇👇

Precision Cancer Drugs Glitter with Promise--If You Can Get Them scientificamerican.com/article/precis… via Scientific American

Packed house at #AMPath23 to see 🌟 lead scientist Debyani Chakravarty, PhD 🇺🇦 present OncoKB™, the U.S. FDA recognized cancer knowledge base, bringing precision oncology to patients at Memorial Sloan Kettering Cancer Center and now around the 🌏

Now online in Cancer Discovery: #DeepLearning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data Madison Darmofal Michael Berger Quaid Morris doi.org/10.1158/2159-8… Memorial Sloan Kettering Cancer Center

Great to meet Kanika Arora yesterday at #AACR24 - her work was featured in the AACR Journals collection on Cancer Disparities!

🚀 We are extremely proud to announce the launch of MSK-ACCESS® powered with SOPHiA DDM™! We want to warmly thank everyone who joined our launch event in Switzerland and contributed to make this insightful gathering a success! #oncology #MSKACCESS #MSK #cancerresearch #AI

Thrilled to share our recent work in Cell ✨ We study the extent to which tumor suppressor genes in cancer adhere to Knudson's ‘two-hit’ hypothesis, and their clinical implications. 🧵👇 Also a detailed 🧵 by Ed Reznik below: MSK Department of Pathology & Laboratory Medicine Memorial Sloan Kettering Cancer Center

Excited to share our latest in Nature Medicine✨ We present a detailed clinico-genomic landscape of pancreatic adenocarcinomas With important implications for RAS 🎯 therapies Expertly co-led by Anna Varghese and Maria A Perry. w/Eileen M O’Reilly & colleagues Memorial Sloan Kettering Cancer Center

Things I wish more people knew about doing science in the US (thread):

⬇️ Can’t think of a more innovative, impactful, and incredible example of Team Science! Congrats to the Memorial Sloan Kettering Cancer Center IMPACT team! 👏👏 Michael Berger David B. Solit, MD Marc Ladanyi + many more team members! #AACR25 AACR

Congratulations to the MSK-IMPACT team at MSK for receiving the American Association for Cancer Research (AACR) Team Science Award. The team, led by Michael Berger, David B. Solit, MD, and Marc Ladanyi, is recognized for its pivotal advances in clinical genomic sequencing that have transformed

.Michael Berger, David B. Solit, MD, Marc Ladanyi, and the MSK-Impact team accept the AACR Team Science Award for developing and implementing a groundbreaking next-generation sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25

Congratulations to Memorial Sloan Kettering Cancer Center MSK-IMPACT team and OncoKB™ for receiving the #AACR25 TEAM Science Award! The impact of this team, assay & data to our understanding of cancer biology is unprecedented.